71-Year-Old William Gibson Explores ‘Existing Level of Weirdness’ For New Dystopian SciFi Novel

71-year-old science fiction author William Gibson coined the word “cyberspace” in his 1984 novel Neuromancer. 36 years later he’s back with an even more dystopian future in his new novel Agency. But in a surprisingly candid interview in the Daily Beast, Gibson says he prefers watching emerging new technologies first because “To use it is to be changed by it; you’re…

Quest To Use CRISPR Against Disease Gains Ground

The prospect of using the popular genome-editing tool CRISPR to treat a host of diseases in people is moving closer to reality. From a report: Medical applications of CRISPR-Cas9 had a banner year in 2019. The first results trickled in from trials testing the tool in people, and more trials launched. In the coming years, researchers are looking ahead to more…

Middle-Aged Hearing Loss Doubles Risk of Dementia

“Hearing loss in middle age is associated with higher odds of cognitive decline and dementia in later years,” reports Reuters, citing a large study in Taiwan. Researchers tracked more than 16,000 men and women and found that a new diagnosis of hearing loss between ages 45 and 65 more than doubled the odds of a dementia diagnosis in the next dozen…

Gene-silencing drug for rare hereditary disorder approved for NHS use

A therapy that uses RNA interference to treat the rare condition hereditary transthyretin-mediated amyloidosis has been approved for NHS use in England Source: https://www.newscientist.com/article/2209128-gene-silencing-drug-for-rare-hereditary-disorder-approved-for-nhs-use/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home…